Association between serum 25-hydroxyvitamin D and nephrolithiasis: The National Health and Nutrition Examination Survey III, 1988-94

Nephrology Dialysis Transplantation

Volumn 27, Issue 12, 2012, Pages 4385-4389

  Tang, Jie ^a   McFann, Kim K ^b   Chonchol, Michel B ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Food Science and Human Nutrition   (United States)

Author keywords

25 hydroxyvitamin D; kidney stone disease; Third National Health and Nutrition Examination Survey

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM;

ADULT; AGE; ARTICLE; BODY MASS; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG USE; FEMALE; HISPANIC; HUMAN; HYPERTENSION; KIDNEY SURGERY; LITHOTRIPSY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NEPHROLITHIASIS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SELF REPORT; SEX; VITAMIN BLOOD LEVEL;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; NEPHROLITHIASIS; NUTRITION SURVEYS; VITAMIN D;

EID: 84871182187     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs297     Document Type: Article

References (25)

1. Stamatelou KK, Francis ME, Jones CA et al. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 2003; 63: 1817-1823.
2. Aruga S, Honma Y. [Urolithiasis and calcium metabolism. Renal calcium excretion and urolithiasis]. Clin Calcium 21: 1465-1472.
3. Shen FH, Baylink DJ, Nielsen RL et al. Increased serum 1,25-dihydroxyvitamin D in idiopathic hypercalciuria. J Lab Clin Med 1977; 90: 955-962.
4. Broadus AE, Insogna KL, Lang R et al. Evidence for disordered control of 1,25-dihydroxyvitamin D production in absorptive hypercalciuria. N Engl J Med 1984; 311: 73-80.
5. Berlin T, Bjorkhem I, Collste L et al. Relation between hypercalciuria and vitamin D3-status in patients with urolithiasis. Scand J Urol Nephrol 1982; 16: 269-273.
6. Berlin T, Holmberg I, Bjorkhem I. High circulating levels of 25-hydroxyvitamin D3 in renal stone formers with hyperabsorptive hypercalciuria. Scand J Clin Lab Invest 1986; 46: 367-374.
7. Netelenbos JC, Jongen MJ, van der Vijgh WJ et al. Vitamin D status in urinary calcium stone formation. Arch Intern Med 1985; 145: 681-684.
8. Leaf DE, Korets R, Taylor EN et al. Effect of vitamin D repletion on urinary calcium excretion among kidney stone formers. Clin J Am Soc Nephrol 2012; 7: 829-834.
9. Sakhaee K, Maalouf NM, Kumar R et al. Nephrolithiasis-associated bone disease: pathogenesis and treatment options. Kidney Int 2011; 79: 393-403.
10. Melton LJ, III, Crowson CS, Khosla S et al. Fracture risk among patients with urolithiasis: a population-based cohort study. Kidney Int 1998; 53: 459-464.
11. Lauderdale DS, Thisted RA, Wen M et al. Bone mineral density and fracture among prevalent kidney stone cases in the Third National Health and Nutrition Examination Survey. J Bone Miner Res 2001; 16: 1893-1898.
12. Heilberg IP, Martini LA, Szejnfeld VL et al. Bone disease in calcium stone forming patients. Clin Nephrol 1994; 42: 175-182.
13. Suda T, Ueno Y, Fujii K et al. Vitamin D and bone. J Cell Biochem 2003; 88: 259-266.
14. DeLuca HF. The vitamin D story: a collaborative effort of basic science and clinical medicine. FASEB J 1988; 2: 224-236.
15. Shevde NK, Plum LA, Clagett-Dame M et al. A potent analog of 1alpha,25-dihydroxyvitamin D3 selectively induces bone formation. Proc Natl Acad Sci USA 2002; 99: 13487-13491.
16. Gardiner EM, Baldock PA, Thomas GP et al. Increased formation and decreased resorption of bone in mice with elevated vitamin D receptor in mature cells of the osteoblastic lineage. FASEB J 2000; 14: 1908-1916.
17. The Third National Health and Nutrition Examination Survey (NHANES III 1988-94) Reference Manuals and Reports [book on CD-ROM]. Bethesda: National Center for Health Statistics, 2002 PMID 19091317.
18. Cirillo M, Laurenzi M. Elevated blood pressure and positive history of kidney stones: results from a population-based study. J Hypertens Suppl 1988; 6: S485-S486.
19. Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. J Am Med Assoc 2005; 293: 455-462.
20. Martins D, Wolf M, Pan D et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2007; 167: 1159-1165.
21. Seyhan S, Yavascaoglu I, Kilicarslan H et al. Association of vitamin D receptor gene Taq I polymorphism with recurrent urolithiasis in children. Int J Urol 2007; 14: 1060-1062.
22. Nishijima S, Sugaya K, Naito A et al. Association of vitamin D receptor gene polymorphism with urolithiasis. J Urol 2002; 167: 2188-2191.
23. Ozkaya O, Soylemezoglu O, Misirlioglu M et al. Polymorphisms in the vitamin D receptor gene and the risk of calcium nephrolithiasis in children. Eur Urol 2003; 44: 150-154.
24. Ferreira LG, Pereira AC, Heilberg IP. Vitamin D receptor and calcium-sensing receptor gene polymorphisms in hypercalciuric stone-forming patients. Nephron Clin Pract 2010; 114: c135-c144.
25. Gunes S, Bilen CY, Kara N et al. Vitamin D receptor gene polymorphisms in patients with urolithiasis. Urol Res 2006; 34: 47-52.